Xuan Tan

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak et al. · The Lancet · 2021 · 454 citations · Full text

Medicine, Oncology, Pharmacology +12

EGR1 decreases the malignancy of human non-small cell lung carcinoma by regulating KRT18 expression

Huihua Zhang, Xiaojia Chen, Jiakang Wang et al. · Scientific Reports · 2014 · 86 citations · Full text

Medicine, Molecular Biology, Oncology +16

Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma

Baoqing Tian, Xiaojia Chen, Huihua Zhang et al. · Oncotarget · 2017 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +17

miR-671-5p Blocks The Progression Of Human Esophageal Squamous Cell Carcinoma By Suppressing FGFR2

Xiaoyan Li, Changjun Nie, Baoqing Tian et al. · International Journal of Biological Sciences · 2019 · 38 citations · Full text

Medicine, Cancer Biology, Oncology +16

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance

Joshua W.D. Tobin, Gabrielle Rule, Katherine Colvin et al. · Blood Advances · 2019 · 26 citations · Full text

Medicine, Hematology, Oncology +15